Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs Superior Remedies
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
vs
Verdict62/ 100
Grade C · #312Superior Remedies
Superior Remedies runs three named programs — semaglutide, tirzepatide, and a dedicated GLP-1 Microdose protocol for longevity and body composition — and publishes no price for any of them.
Visit Superior RemediesThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 62/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Superior Remedies still earns its place — readers who want a low-dose protocol designed on its own terms rather than a smaller version of a weight-loss plan, and who do not mind starting an eligibility check to learn the price.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results60
92
Real-world results60
97Price honesty25
97
Price honesty25
96Prescriber access80
96
Prescriber access80
88Formulary choice55
88
Formulary choice55
95Cancellation fairness82
95
Cancellation fairness82
93Member support72
93
Member support72
Price, coverage & features
| Metric | CoreAge Rx | Superior Remedies |
|---|---|---|
| Verdict Score | 94/100 | 62/100 |
| Grade | A | C |
| Semaglutide | $149/mo | Not disclosed |
| Tirzepatide | $349/mo | Not disclosed |
| Coverage | All 50 states | All 50 states (telehealth nationwide) |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | No | No |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Superior Remedies
What we like
- Runs a dedicated GLP-1 Microdose program with its own page, framed for metabolic health and body composition rather than aggressive weight loss
- Publishes a clinical exclusion that turns business away: patients with significant weight to lose are told they would be better served by a standard GLP-1 protocol
- Charges nothing if you are not approved, and states telehealth availability in all 50 states
- Names its exclusions plainly, including medullary thyroid carcinoma or MEN 2 history and pregnancy
The caveats
- ⚠⚠ No price on any program page — the only public figure is a homepage headline labeled a limited-time offer and attached to the general pitch rather than to a program
- ⚠ No milligram figure anywhere, so "microdose" describes an intent rather than an amount
- No compounding pharmacy is named
- Compounded GLP-1s are not FDA-approved
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
Readers who want a low-dose protocol designed on its own terms rather than a smaller version of a weight-loss plan, and who do not mind starting an eligibility check to learn the price.
Visit Superior Remedies Read the full Superior Remedies review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for Superior Remedies does the reverse.
Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.